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This work was begun  (1,  2)  in an attempt  to discover if there is a  common 
basis for the therapeutic  effect of colchicine ill acute gouty arthritis  (3) and for 
its effect on the mitotic apparatus (4). Effects of colchicine have been attributed 
to decreased protoplasmic viscosity in both dividing  (5) and resting (6,  7) cells. 
Experiments  in  cell  systems  hitherto  employed  to  study  colchicine  action, 
though  often  elegant  in  design,  have  been  technically  complex  and  slow  in 
operation.  In the present  work we have introduced  a  new system in which  to 
study the action of colchicine: the frog melanocyte, x In this cell type, changes in 
cytoplasmic  viscosity  are  effected  rapidly  and  reversibly  (8)  and  are  easily 
controlled  and measured  (9,  10).  Frog skin  darkens when treated  with melan- 
ocyte-stimulating  hormone  (MSH).  Darkening,  measured  by  reflectance,  is 
due  to  dispersion  of melanin  granules  in  melanocytes,  and  is  thought  to  be 
accompanied  by  a  gel-to-sol  cytoplasmic  transformation.  When  washed,  the 
skin  lightens,  with  aggregation  of melanin  granules  and  cytoplasmic gelation. 
In using this model to study the effect of colchicine,  observations were ilmde 
which  led  to  a  general  theory  of colchicine  action  and  to  the  resultant  possi- 
bility of using colchicine to construct biophysical models of other cell systems. 
Methods 
Preparation of Frog Skin.--Skin from the frog Rana pipiens was prepared and mounted on 
rings as previously described  by Shizume et al.  (9). Four samples were obtained from each 
frog, two from the legs and two from the thighs. Thus four frogs supplied sixteen skin samples, 
arranged as follows, after Wright and Lerner (10). 
Group A  LL1  LT2  RT3  RL4 
Group B  RL1  LL2  LT3  RT4 
Group C  RT1  RL2  LL3  LT4 
Group D  LT1  RT2  RL3  LL4 
The first letter L or R refers to the left or right extremity of the frog. The second letter L or 
T refers to leg or thigh. The number 1, 2, 3, or 4 refers to the frog used. This arrangement was 
* This investigation  was supported by grants from the  National  Institutes  of Health: 
USPHS 1-P3-AM-19,864-01 and USPHS CA-04679-06. 
:~ Special Fellow of the National Institute of Arthritis and Metabolic Diseases. 
x This dermal melanin-bearing  cell is also referred  to as a mdanophore. 
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designed to compensate for variations in reactivity of skin from one frog to another, as well as 
among different areas of a given frog. Note that each group contains one skin specimen from 
each frog and one from each area sampled. Thus for any single experiment one control group 
and up to three experimental groups were available. 
All skin specimens were  soaked in four changes of frog Ringer's solution over a  period 
greater than 1 hour before any observations were made. (A change of Ringer's solution is also 
referred to as a  "wash.") 
Measurement of Melanin Granule Dispersion.--Changes in the state of dispersion of melanin 
granules within melanocytes were measured as changes in reflectance when the whole skin 
specimen was placed over a search unit attached to a photoelectric meter. The procedure was 
as described previously (9), except for the establishment of the scale  of reflectance: for the 
white enamel disc and green filter (both of which accompanied  the meter),  the sensitivity 
control knobs were set at 65. All readings of skin were taken without a filter and with the skin 
immersed in approximately 20 ml of solution in a 50 ml beaker.  The reading of a given skin 
specimen after initial soaking in Ringer's solution was taken  as its baseline, or zero value; 
subsequent increase or  decrease in  reflectance  units was  measured  from  basefine.  Sixteen 
specimens could  be read in a  5  minute period.  The graphs were prepared  by totafing the 
changes in reflectance within each treatment group and plotting these values against time. 
Preincubation with Colchicine.--Each group of skins preincubated with colchicine received 
the drug after the basefine readings. After the specified period of preincubation, the group was 
washed. Before the second set of readings, all groups (including control) were washed a second 
time, except for the experiments depicted in Text-figs. 2 a and 2 b, in which they were washed 
but once, and in Text-fig. 10 a, in which they were not washed. 
Solutions Used.- 
Frog Ringer's solution: The suspending medium was prepared as previously described (10). 
The pH was between 7.3 and 7.8 at the start of a given experiment. All test substances were 
dissolved in Ringer's solution before use. 
Colchicine: Colchicine USP  (Sigma Chemical Company,  St. Louis)  was the  preparation 
generally used. The drug at 10  4  ~ was freshly prepared for each experiment and protected from 
light before use. To specified skins in 20 ml of Ringer's solution, colchicine was added to 9 
X  10  -~, 5 X  10  -n, or I  X  10  -~ ~r. Addition of colchicine at these concentrations did not affect 
the pH of the Ringer's solution. 
In the experiments depicted in Text-figs. 2 a, 2 b, and 10 a, colchicine USP is designated 
"C-1." For these studies approximately 1 gm of C-1 was dried in vacuo at 80°C for  over 10 
hours,  yielding the  sample  designated  "C-2."  Five hundred  mg  of  the  latter  sample was 
dissolved in trlple-distilled water and lyophilized, yielding sample "C-3." In solution at 10  4 
M, C-1 and C-2 had a faintly sweet odor; C-3 did not. 
Mela~ocyte stimulating hormone (MStt): Beef posterior pituitary powder  (Armour Phar- 
maceutical Company, Kankakee,  Illinois) was extracted with water  and lyophilized as  de- 
scribed previously (9). One mg of the lyophilized product was diluted so that each beaker 
received 0.2 ml of the final product containing 10 units of MSH (9). 
Other solutions: Other substances were used in final concentrations as follows: caffeine, 5.2 
X  10  -3 M; adenosine triphosphate disodium (ATP), 0.9 X  10  ~  ~; ethyl acetate, 0.8 X  10  -~ 
M;  N-acetyl-5-methoxytryptamine (melatonin), 4.3  X  10  -~° ~r; hydrocortisone  sodium  suc- 
einate (hydrocortisone), 1 X  10  4  ~r; L-arterenol bitartrate hydrate (norepinephrine), I X  10  -'3 
M. 
RESULTS 
The Behavior of Control Preparations (Text-fig.  1).--In frog skin prepared by 
the method  described,  reflectance  remains  constant  over  several  hours.  With 
further changing of Ringer's solution, reflectance may  increase slightly. STEPHEN  E.  MALAWISTA  363 
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T~x~-FIo. 1. The behavior of control preparations (A - --/k : No MSH) (see text). 
The addition of a  standard mount  of MSH to a  group of skins results in a 
rapid decrease in reflectance, maximal at 60 to 90 minutes. The effect is reversed 
by changing the Ringer's solution, whereupon  the reflectance returns to  near 
baseline. 
The Effect of Preincubation with Colckicine.-- 
Characteristics  and reproducibility (Text-figs. 2 a and 2 b  ): 
Three different samples of colchicine (see Methods) were used, all at 9  ×  10  -~ m 
Each sample was preincubated for 15 minutes with a group of skins, the fourth group 
serving as control. Then all four groups were washed, and MSH was added to each. 
The results for the three experimental groups were identical (Text-fig. 2  a). When 
MSH was added, groups preincubated with colchicine darkened more than did the 
control group. (Unlike MSH controls, darkening was not maximal at 60 to 90 minutes, 
but continued slowly thereafter.) Ninety minutes after the addition of MSH, all four 
groups of skins were washed.  Mter  washing, reversal of MSH  darkening occurred 
readily in control skins; however, in the three groups preincubated with colchieine, 
inhibition of lightening was apparent. A second wash, 90 minutes after the first one, 
was sufficient to bring the reflectance of the control group  back to baseline. In con- 
trast, the three preincubated groups maintained comparable degrees of inhibition of 
lightening. 
The experiment was repeated using a shorter preincubation time, 5 minutes instead 
of 15 (Text-fig. 2 b). The results were the same except for less inhibition of lightening. 364  ACTION  OF  COLCHICINE 
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T~x¢-Fi6s. 2 a and 2 b. The effect of preincubation with three different samples  of co]- 
chicine: characteristics and reproducibility of the effect (see text). 
Summary: Preincubation of frog skin with colchicine causes an increase in 
darkening  induced  by  MSH  as  compared  to  controls,  and  an  inhibition  of 
subsequent lightening. 
Dose-response  relationships (Text-figs. 3 and 4) : In the preceding studies,  the 
results with two different preincubafion times suggest a  dose-response relation- 
ship (i.e.,  dosage  =  concentration  X  preincubation time). However,  the  two 
experiments were  done  with groups of skins from  different frogs and  are not 
strictly comparable. 
In the next four experiments, for a given group of skins, either  concentration of 
colchicine or preincubation time was varied, while the other was held constant. Pre- 
liminary studies with eolchicine at 9  ×  10  -~ M showed that a 30 minute preincubation 
gave strong inhibition of lightening after MSH. At the lower limit, a 30 second pre- 
incubation had  virtually no  effect.  Varying  the preincubation  time  in  this  range 
resulted in a  commensurate variation in inhibition of lightening (Text-fig. 3 a). In- 
crease in MSH darkening over controls occurred in all three preincubated groups. 
When the colchicine concentration was decreased to 5  X  l0  -~ ~r in a different set of 
skins (Text-fig. 3 b), the results were similar, but with less inhibition of lightening in 
the three preincubated groups. 
In the third and fourth experiments, preincubafion times were held constant at 30 
and 10 minutes, respectively, while the colchicine concentration was varied from 9  × STEPHEN  E.  MALAV¢-ISTA  365 
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10  -6 to 1 X  10  -s ~  (Text-figs.  4 a and 4 b). For a given preincubation time, the degree 
of inhibition of lightening varied directly with  the concentration of colchicine.  With 
colchicine at 1 X  10  -5 ~, there was neither increased MSH darkening nor inhibition 
of subsequent lightening, even with a 30 minute preincubation. 
Summary: Inhibition of lightening  by colchicine  is  dependent  on both  its 
concentration and preincubation time. 
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TEx'r-FIos.  5 a and 5 b. Attempt to "wash out" the colchicine effect from preincubated 
preparations  (see text). 
Attempt to "wash out" the colchicine effect from preincubated preparations  (Text- 
figs.  5 a  and  5 b):  In  the  preceding  studies,  both  preincubated  and  control 
groups were washed twice before addition of MSI-I. The question arose whether 
additional  changes of Ringer's solution might reverse the effect of preincuba- 
tion with colchicine. 
In the first part of the next experiment (Text-fig. 5 a) the design was the same as ia 
Text-figs. 3 a and 3 b, using a colchicine concentration of 9  ×  10-" za and a 5 minute 
preincubation time. However, in the other two groups of skins (Text-fig. 5 b), after 
the same preincubation conditions and double wash, MSH was not added immediately. 
Instead, the groups were rewashed at 30 minute intervals for 3 hours, and only then 
was MSH added. Subsequent reading and washing were carried out at the same in- 368  ACTION OF COLCIIICII~ 
tervals as in Text-fig. 5 a. Despite the frequent washing, a gradual darkening of the 
experimental group in Text-fig. 5 b was noted, resulting in a higher take-off point when 
MSH was finally added (see Text-figs. 10 a and 10 b). Otherwise, the curves in Text- 
figs. 5 a and 5 b are virtually superimposable; i.e., the conditions of washing were not 
sufficient to alter the preincubation effect. Similarly, after MSH darkening was effected 
and the groups had been washed twice over the subsequent 3 hours (Text-figs. 2 to 4) 
subsequent washing was not found to diminish the established degree of inhibition of 
lightening. 
Summary: The effect of preincubation with colchicine could not be "washed 
out" under the conditions described. 
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TlgXT-Fzo. 6. Attempt to exhaust the colchicine solution by successive preincubations (see 
text). 
Attempt to exhaust  the colckicine  solution  by successive preincubations  (Text- 
fig. 6): 
Initially a single group of skins was preincubated for 30 minutes in Ringer's solu- 
tion containing colchicine at 9 ×  10  -6 •.  Several other groups contained only Ringer's 
solution. After 30 minutes, the beakers of another group were emptied, and the fluid 
from each beaker of the first group was transferred to the corresponding beaker of the 
second group. The first group was then washed twice and MSH was added, as in Text- 
figs. 3 a and 3 b. The second group was allowed a 30 minute preincubation, and then its 
fluid contents were transferred to an emptied third group, and so on. In this manner, STEPHEN  E.  MALAWISTA  369 
six groups of s~;-*  were preincubated consecutively for 30 minutes in the same col- 
chicine solution. The three groups plotted in Text-fig. 6 all came from the same four 
frogs. The two experimental  curves describe the first and the sixth  groups of skins 
passed through the same colchicine solution. The two curves are essentially the same, 
as was the curve describing the third passage (not shown in Text-fig. 6). 
Summaxy: The power of a 9  X  10-" M colchicine solution was not diminished 
by passage through it of six successive skins, each for 30 minutes. 
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TExm-FIG. 7. Attempt to alter  the colchiclne effect by a second cycle of darkening and 
lightening (see text). 
Attempt to alter the colchicine effect by a second cycle of darkening and lightening 
(Text-fig.  7): 
The experimental  design was as in Text-figs.  3 a  and 3  b except that,  after  the 
degrees of inhibition of lightening were determined, the experiment began again, with 
addition of MSH to all skins. The preincubations with colchicine occurred only once, 
at the beginning of the experiment. After the initial cycle of darkening and lightening 
had  been measured,  further  addition  of MSH resulted  in  a  comparable  degree of 
darkening to that obtained previously in each group. Moreover, subsequent washing 
again established  inhibition  of lightening,  once more in proportion to  the original 
colchicine preincubafion time. The consecutive curves are superimposable until about 
the tenth hour, when all the groups, including the control, began slowly to darken. 370  ACTION  OF  COLCHIC1-NE 
Summary: After inhibition of lightening following a single exposure to colchi- 
cine had been demonstrated,  a  further addition of MSI-I and washing resulted 
in  essentially  the  same  curves  of increased  darkening  and  dosage-dependent 
inhibition of lightening that had been obtained in the first cycle. 
The effect in relation to darkening agents other than MStt (Text-figs. 8 a to 8 c): 
Substances other than MSH are known to darken frog skin (8). The design of these 
experiments is as in Text-figs. 3 a and 3 b, except that, instead of a  standard dose of 
MSH, the darkening agent used was caffeine, adenosine triphosphate (ATP), or ethyl 
acetate (see Methods). Preincubation with colchicine resulted in an increase in darken- 
ing compared to controls and a  dosage-dependent inhibition of lightening with each 
of these darkening agents substituted for MSH. 
Because  the  colchicine  was  prepared  commercially by precipitation  from  ethyl 
acetate, we were particularly interested in the darkening power of this organic solvent. 
However, 0.8  ×  10-2 ~  was required to produce the degree of darkening seen in the 
control group of Text-fig. 8 c. In another experiment (not shown in Text-fig. 8 c), we 
assumed that 100 per cent by weight of the highest concentration of colchicine used 
(9  X  10  -5 x~) was actually ethyl acetate  (an extreme allowance, as one is a  white, 
odorless powder, the other a  clear, odorous liquid).  Ethyl acetate in this range pro- 
duced  no  significant  darkening.  Moreover,  purification  procedures  (see  Methods) 
resulted in no change in colchicine effect (Text-figs. 2 a, 2 b, and 10 a). 
Summary: The effect of preincubation with colchicine was independent of the 
darkening agent employed. 
The effect in the presence  of lightening agents (Text-figs. 9 a to 9 c): 
Certain substances are known partially to antagonize the darkening effect of MSH. 
These include melatonin, hydrocorfisone, and norepinephrine, in concentrations as low 
as 5  X  10  -le, 6  X  10  -7, 6  X  10-  7 •,  respectively (11).  The  design  of these  experi- 
ments is the same as in Text-figs. 3 a and 3 b except that, instead of attempting to re- 
verse darkening by washing, we added a lightening  agent--either  melatonin,  hydro- 
cortisone,  or  norepinephrine  (see  Methods).  With  each  substance,  the  groups 
preincubated  with  colchicine again  showed a  dosage-dependent  inhibition of light- 
ening. 
Sl~mmary:  The effect of preincubation with  colchicine  was  independent  of 
the method used to reverse darkening by MSI-I. 
The effect in the absence of a darkening agent (Text-figs. 10 a, 10 b, and 11): 
In the next experiment (Text-fig. 10 a) the same three preparations of colchicine as 
in Text-figs. 2 a and 2 b were added to three groups of skins, all at 9  X  10  -5 ~r.  No STEPHEN  ~E.  I~ALAWISTA  371 
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darkening agent was added, and the groups were not washed. No difference from the 
control group was noted for about 1 hour. Then the colchicine treated groups began 
gradually to  darken,  all at comparable rates. The  darkening was not reversed by 
washing one group  (C-I)  4~  hours  after  addition of colchicine. Nine  hours  after 
addition (not shown in Text-fig. 10 a), the three treated groups showed a net decrease in 
reflectance of between 61 and 70 units. 
In the experiment depicted in Text-fig. 10 b, three groups of skins were preincubated 
with colchicine, 9  X  10  --5 ~r, for variable periods of time. No darkening agent was 
added. Again, no effect was noted for about 1 hour. Then the preincubated groups 
began gradually not only to darken but to do so in proportion to the time of pre- 
incubation. 
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TExT-FIGs. 10 a and 10 b. The colchicine effect in the absence of a darkening agent: Text, 
fig. 10 a. Three different samples of eolchicine. Text-fig. 10 b. Dose-response relationships (see 
text). 
In the experiment depicted in Text-fig. 11, all four groups of skins were preincubated 
with colchicine, 9  X  10  -s ~r for 30 minutes. Then the lightening agent, melatonin, was 
added to two groups. The two groups so treated showed less subsequent darkening 
than the two other groups. Two and one-half hours after the addition of melatonin, 
one group tha  t had received melatonin and one group that had not were washed twice. 
No reversal of darkening occurred in the washed groups as compared to their unwashed 
controls. Six hours after the addition of melatonin, MSH was added to all four groups 
(not shown in Text-fig. 11). Continued activity of melatonin in the melatonin-treated, 
unwashed group was indicated by less darkening than in the other three groups after 
addition of the standard dose of MSH. 
Summary: Colchicine alone produces a  gradual,  irreversible, dosage-depend- 
ent darkening over several hours. This darkening was inhibited by addition of 
the lightening agent,  melatonin. 374  ACTION OF COLCHICINE 
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TExT-FIo. 11. The colchidne effect in the absence of a darkening agent: addition of mela- 
tonin (.--. : No melatonin, no wash) (see text). 
The e~ect shown in conseculive photomicrographs (Figs. 1 to 3): 
Figs. 1 a to 1 d. Two of four samples of skin from a single  frog were preincubated 
with colchicine, 9  X  10  -5 ~r for 30 minutes (samples a and c). Mter these preincuba- 
fions, all four samples still appeared light. Microscopically, one saw black dots, each 
of which depicted melanin  granules aggregated about  the  nucleus of an otherwise 
invisible melanocyte. 
Figs. 2 a to 2 d. Next, MSH was added to one preincubated skin and to one control 
skin (samples a and b). One and one-half hours later, the samples so treated appeared 
dark; microscopically, melanin granules were dispersed,  outlining the cells in which 
they resided (Figs. 2 a and 2 b). Sample c, which had been preincubated with colchicine 
but not incubated with MSH, was darkened somewhat; dispersion of melanin granules 
in melanocytes was not marked (Fig. 2 c). Sample d was unchanged in the gross and 
microscopically (Fig. 2 d). At this stage, the decrease in reflectance of the individual 
samples a to d was, respectively, 45, 35, 13, and 3. 
Figs. 3 a to 3 d. All skin samples were washed both after the second set of photo- 
micrographs and again 11~ hours later. About 1 hour after the second wash, sample a 
was still dark; granules in melanocytes remained  dispersed  (Fig.  3 a).  In contrast, 
sample  b,  which  had  not  been  preincubated  with  colchicine,  was  light  again,  its 
granules aggregated (Fig. 3 b).  Sample c remained darkened somewhat, its granules 
tmrtially dispersed  (Fig. 3 c).  Sample d continued unchanged (Fig. 3 d). Decrease in 
reflectance of samples a to d was, respectively, 37, 2, 19, and 4. 
DISCUSSION 
The Melanocyte ModeL--The melanocyte model fulfilled every expectation. 
Its first attribute  is simplicity; one or more experiments  could be carried out 
in a  single day. Next,  the colchicine effect was both reproducible and dosage- STEPHEN  E.  MALAWISTA  375 
dependent  within  the  specified  limits  of  concentration  and  exposure  time. 
Finally, after the period of preincubation, colchicine was no longer required in 
the ambient Ringer's solution.  This last attribute is of special  importance, as 
it allowed the effects of other agents to be separated from that of colchicine. 
Recognition of Colchicine Action.--Mter preincubation  with colchicine,  the 
melanocytes were altered. However, alteration was not immediately apparent, 
at least by reflectance  measurements. That it had occurred was  demonstrable 
in two ways: by addition of a darkening agent and washing, or simply by wait- 
ing. Addition of a darkening agent resulted in an increase  of darkening in frog 
skins pretreated with colchicine compared to controls,  even though colchicine 
was no longer  present  in  solution.  Furthermore,  the  subsequent washing  of 
these skins revealed a dosage-dependent inhibition of lightening,  an inhibition 
whose potential was established before addition of the darkening agent (Text- 
figs. 3 and 4). Thus, use of the darkening agent provided early recognition of a 
cellular  change produced previously by colchicine. So long as it could produce a 
reversible darkening,  the chemical structure  of the  darkening  agent  seemed 
irrelevant; the agents used included a  peptide hormone  (MSH)  (Text-figs.  3 
and  4), a pharmacologically active purine  (caffeine),  a  nucleotide present  in 
all living  cells (ATP), and a simple  organic  solvent (ethyl acetate)  (Text-figs. 
8 a to 8 c). Nor did the colchicine effect depend upon the method employed to 
reverse darkening by MSH; dosage-dependent inhibition of lightening  occurred 
whether lightening  was achieved by the hormones,  melatonin,  hydrocortisone 
or norepinephrine  (Text-figs.  9 a to 9 c); or simply by removal of MSH from 
the medium (Text-figs. 3 and 4). 
The second way to demonstrate alteration in the melanocyte by preincuba- 
tion with colchicine was simply to wait. After an interval of about 1 hour during 
which no change was noted, thepreincubated skins began gradually and irre- 
versibly to darken, again in a  dosage-dependent manner  (Text-fig.  10 b). This 
method provided late recognition of the cellular change produced by preincuba- 
tion with colchicine, a change eventually expressed as dosage-dependent inhibi- 
tion of tightening.  Addition of the lightening  agent melantonin delayed recogni- 
tion of this change still  further  (Text-fig.  11). 
Colchicine Action in Terms of Cytoplasmic Viscosity.--As noted earlier,  dis- 
persion of melanin granules in melanocytes is thought to be accompanied by a 
reversible gel-to-sol cytoplasmic transformation  (8). In such a system, reflect- 
ance becomes a measure of cytoplasmic viscosity as well as of granule dispersion. 
If we assume that  colchicine  does not disturb the relation between viscosity 
and dispersion,  we can substitute the word "viscosity" for "reflectance." The 
resultant schema is depicted in Text-figs.  12 and 13. It is best explained by a 
single  effect of colchicine  on the dynamic equilibrium between protoplasmic 
sol and gel, where the most viscous conditions can no longer be developed. By 376  ACTION  O~P  COLCHICINE 
adding agents that affect the equilibrium, we alter the speed with which we can 
recognize the action of colchicine; we do not alter the basic action itself. 
Analogous Action of Colchicine in Other Systems.--We thus arrive at the con- 
cept that the action of colchicine, i.e.  its binding to cellular targets,  is rapid 
and dosage-dependent, but that the recognition of that action depends on the 
state of the protoplasm and its alteration by active agents. If this concept can 
be applied to other cell systems, it may allow plausible explanations for hereto- 
fore apparently unrelated colchicine effects. Such effects have been noted in 
regard to (a) the "activity" and "efficiency" of colchicine, (b) the relation of 
colchicine requirement to degree of gelation, and (c) agents that appear syner- 
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Tgx-r-Fm. 12. The effect of colchicine on the frog melanocyte in terms of cytoplasmic 
viscosity: Inhibition of recognition. Preincubation with colchicine  produces a dosage-depen- 
dent decrease  in cytoplasmic  viscosity.  The effect,  at least in the short run, is irreversible.  The 
process requires time; we refer to its appreciation as 'qate recognition." Addition of a lighten- 
ing agent inhibits the irreversible  decrease  in viscosity,  and thus retards further the apprecia- 
tion of colchicine  action. We refer to the result as "very late recognition" (or, as a ]knit, "no 
recognition"). 
gistic or antagonistic to colchicine. Each of these effects in other systems has its 
counterpart in the melanocyte model. 
Activity and efficiency: In studying threshold colchicine-like effects of many 
substances on root tips of the onion bulb, Allium Cepa, Ostergren (12) saw the 
need to distinguish between activity, measured by the inverse of the "activity 
threshold," and efficiency, representing the ability of a substance to produce a 
z~isible effect.  In  the  melanocyte model  a  simpler  approach  is  possible:  the 
activity  of  colchicine is  directly dosage-dependent,  while  the  efficiency (or 
"recognition," in the model)  is a  variable which can be increased, at a  given 
time prior to the maximal effect, by adding  a  darkening agent and washing 
(Text-figs. 2 a, 2 b, and 13), or decreased by adding a lightening agent (Text- 
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Relation of colchicine requirement  to degree of gelation: In studying formation 
of the  (gelated)  mitotic spindle  in the grasshopper  neuroblast,  Gaulden and 
Carlson noted that the more completely the spindle is developed at the time 
of exposure to colchicine, the greater is the concentration of colchicine required 
to destroy it or to prevent its further development (13). Here we compare the 
gelafion that occurs with cell division to the gelation that occurs when melanin 
granules  aggregate.  Godman  (7)  obtained  analogous  results  in  an  entirely 
different system. He observed the disruption by colchicine of sarcoblast ribbons 
grown in tissue culture of striated muscle. They progressed (reversibly i) from 
organized, straplike,  birefringent,  pulsatile  units to segmented,  homogeneous, 
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TExt-FIG.  13.  The effect of colchicine on the frog melanocyte in terms of cytoplasmic 
viscosity: Potentiation of recognition. (See Text-fig. 12 re "late recognition"). Addition of a 
darkening agent potentiates the recognition of colchicine action; after subsequent washing or 
addition of a lightening agent, what would have been a reversible decrease in viscosity is main- 
tained in a dosage-dependent manner attributable to prior treatment with colchicine. We refer 
to the resultant rapid appredation of colchicine action as "early recognition." 
expanded globules. The effect was directly proportional  to the concentration 
of colchicine and inversely related to the degree of differentiation of the sarco- 
blast. Here the less differentiated sarcoblast fiber may be compared to the less 
viscous  cytoplasm of the  dark melanocyte. Restating the findings  of these 
authors, one may say that they were able to recognize the action of colchicine 
earlier  when dealing with less gelated structures. 
Supporting this contention is Godman's observation that the maximal colchi- 
cine effect occurred in 4 to 5 days whether or not colchicine was present in the 
medium after the standard 48  hour treatment. That is, the optimal dosage 
(concentration  X  time of exposure) was reached after 2 days but the maximal 378  ACTION OF COLCIIICIN'E 
effect was seen only after 4 or 5 days. In the melanocyte model, this delayed 
response corresponds to "late recognition" (Text-figs. 10 a, 10 b, and 12). 
Synergism and antagonism: Working with explants  or  chicken fibroblasts, 
Lettr6 (14)  found that a  variety of substances, with little or no antimitotic 
activity of their own, can increase the antimitotic activity of colchicine.  The 
mechanism of action of these synergists was obscure.  In the present studies, 
the reversible darkening agents were "synergists" of colchicine; their use was 
followed, after  a  fixed interval,  by more  inhibition of  lightening  than  was 
apparent with colchicin¢  treatment alone. Moreover, in the melanocyte model 
an explanation of synergism is possible in terms  of early recognition of the 
action of colchicine (Text-fig. 13). Since the specific action of colchicine must 
have taken place in the preincubation period, we have said that the darkening 
agents only allowed the prompt recognition of pre~ious colchicine action. Con- 
versely, any substance  with a  transient ability to  darken  frog  skin--or,  in 
general terms,  to  reduce protoplasmic viscosity--would,  on  the  addition of 
colchicine, have this ability amplified and maintained. 
"Antagonism" may be viewed in a  similar light: any substance capable of 
increasing or maintaining protoplasmic viscosity would appear,  after a  fixed 
interval, to "antagonize" the action of colchicine.  By this definition, melatonin 
was such a  substance,  whether it was inhibiting (Text-fig.  11)  or permitting 
(Text-fig. 9 a) recognition of colchicine action. 
Reversibility.--One of the most striking and significant aspects of the anti- 
mitotic effect of colchicine is reversibility (15); on removal of an optimal dosage 
of colchicine, the spindle will ultimately reform and the cell will divide. Simi- 
larly, reversibility of colchicine effects on resting cells has been demonstrated. 
Godman studied the ability of colchicine,  in concentrations as low as 10  -7 to 
10-8 ~r, to cause disruption of sarcoblast ribbons in tissue culture (7). The result 
was segments which were markedly shortened and widened, and of diminished 
consistency. On withdrawal of the drug, the nucleated segments were capable 
of regeneration, usually requiring a fortnight for restitution. Mizurski studied 
the effects of colchicine,  10  -3 to 10--  ~  M, on hanging drop cultures of fibroblasts 
(6). He watched the initially organized colony of radially arranged cells become 
disrupted, the cells rounded or polygonal and independent of each other. Colchi- 
cine was thought to have affected the sol-gel  equilibrium of the cortical layer 
of the  resting  cell.  Again the  effect was  reversible.  Fortunately, in  the few 
hours during which the melanocyte model operates, the effect of colchicine is 
not reversible (Text-figs. 5 a and 5 b and text). As has been noted, this fortuitous 
circumstance allows an analysis of colchicine action that would not otherwise 
be possible. 
Colchicine in Acute Gouty Arthritis.- 
Recent work has allowed a  tentative approach  to understanding  the therapeutic 
and prophylactic action  of colchlcine in acute gouty arthritis. Prerequisite  to this STEPHEN E. MALAWISTA  379 
approach were the findings that (a) sodium urate crystals are very frequently present 
in  the synovial fluid of gouty patients  (16), and  (b)  intraarticular  or subcutaneous 
injections of such crystals in gouty and non-gouty patients and in dogs results in an 
inflammatory reaction  (17,  18).  In the synovial fluid during both spontaneous acute 
attacks and those induced by injected crystals, there is leukocytosis and phagocytosis 
of crystals (17, 19). Furthermore, the degree of phagocytosis can be correlated with the 
clinical severity of the attack, spontaneous or induced (17). The following events have 
been suggested in gouty inflammation  (17,  20):  (a)  Urate microcrystals precipitate 
from  supersaturated  body  fluids.  (b)  Under  certain  conditions,  an  inflammatory 
response  occurs,  manifested  by leukocytosis  and  phagocytosis  of crystals.  (c)  The 
metabolic products of the inflammatory response are thought  to favor further pre- 
cipitation of urate, and a  vicious cycle occurs, a  cycle driven by the products of in- 
flammation. 
Colchicine is thought to break the inflammatory cycle (20,  21). Administration of 
colchicine cured severe inflammatory reactions elicited by the intraarticular injection 
of microcrystalline  sodium urate  (17).  Pretreatment with  therapeutic  amounts  (for 
gout)  of colchicine resulted in a  diminished inflammatory response to urate crystals 
injected intra-articularly  or subcutaneously in gouty volunteer subjects  (21). 
Of the various elements of the inflammatory response that might be affected by 
colchicine,  the polymorphonuclear leukocyte is an especially likely target.  It is the 
predominant cell type present in  the  synovial fluid of inflamed gouty joints. It is a 
cell type known to be sensitive to the larger doses of colchicine that inhibit mitosis (22); 
a  colchicine analogue, desacetylmethylcolchicine, is used in the treatment of chronic 
granulocytic leukemia (23). Finally, the ameboid functions of the polymorphonuclear 
leukocyte demand  frequent,  reversible changes in cytoplasmic viscosity: in order to 
reach the synovial fluid, it must stick to the wall of a blood vessel, undergo diapedesis, 
wander through the tissues, and eventually arrive in the target area, where its phago- 
cytic  function  comes  into  play.  Results  from  the  melanocyte model  suggest  that 
transient, reversible gel-to-sol reactions will be amplified and maintained by colchicine 
action. If colchicine were to affect the cytoplasm of the polymorphonuclear leukocyte 
in a  similar manner,  the result would be interference with the consecutive ameboid 
activities listed above. Such interference might slow the inflammatory reaction enough 
to break the propagated cycle. 
There  is  already some evidence in  support  of this  hypothesis.  Under  phase  mi- 
croscopy at 37 to 39 degrees centigrade, treatment with colchicine (10  -a 5) resulted 
in  rounding  up  of human  polymorphonuclear leukocytes  as  compared to  controls, 
with decrease in formation of pseudopods and cessation of mobility (2). By using as 
a measure of mobility the numbers of leukocytes that crossed a millipore falter in re- 
sponse to a  chemotactic stimulus, inhibition by colchicine could be detected in very 
low concentration (about 10  -~ ~) (24). In addition, treatment with colchicine (2.5  X 
10--e ~a) interfered with some biochemical functions associated with phagocytosis of 
urate crystals by human leukocytes in vitro (25). 
Colchicine  Action in Relation to A TP and Contractile  Protein.--The mitotic 
spindle  is  an  oriented,  gelated,  birefringent  structure  that  responds  to  low 
concentrations  (<10  -3 ~)  of colchicine by dissolution  and contraction  (4,  26). 
Inou6  has  postulated  that  oriented  and  non-oriented  material  form  a  labile 380  ACTION OF COLCEICINE 
equilibrium in the mitotic apparatus.  Colchicine is thought to disorganize the 
orientation of the micelles in the astral rays and spindle fibers.  Similar events 
are thought to occur in the anaphase movement of chromosomes, with local 
reduction in the quantity of oriented material and the consequent shortening 
of chromosomal fibers. 
From "fiber models" (27),  the mitotic apparatus has been viewed as a con- 
tractile system of the actomyosin type. In explants of chicken fibroblasts, col- 
chicine was thought to inhibit the action of ATP (14), but this conclusion has 
been challenged (28).  In melanocytes, Lerner and Takahashi  (8)  have sum- 
marized the evidence, by no means complete, for a  birefringent, gelated and 
contractile network imbedding the melanin granules, and for the participation 
of ATP in the reversible gel-to-sol reaction effected by MSH. In the present 
studies, ATP was employed as just one of a  number of reversible  darkening 
agents  (Text-fig.  8 b);  as  such  it potentiated  the  colchicine effect. However, 
since we did not examine the biochemical effects of exogenous ATP, or of any 
other darkening agent, we cannot speculate usefully on the possibility of an 
"actomyosin-like" target. 
Perhaps a parallel may be drawn between our results and those of Angevine 
(29), who studied nerve destruction by colchicine in mice. If ATP (10  -1 ~r) was 
added to the colchicine (10  -2 ~) solution, there was a pronounced augmentation 
of colchicine neuropathy as compared to the effect of the colchicine solution 
alone. One wonders if the author was observing disorganization by colchicine 
of axonal elements, with potentiation by ATP similar to that seen in the melan- 
ocyte model (Text fig. 8 b). Indeed, Hoffman (30), studying an inhibitory effect 
of colchicine on axon sprouting from the partially deneurotized sciatic plexus 
of the rat, concluded that colchicine reduced the viscosity of the axogel (the 
cortical layers of the axoplasm). 
The Action  of Colchicine  in  Gelated, Protoplasmic  Cell Systems:  A  General 
Formulation.--The  findings in  the melanocyte model have led us to suggest 
that colchicine opposes  forces within the cell which support protoplasmic vis- 
cosity, i.e. promote the organized state of elements concerned with structure 
and movement; while it allows free rein to those forces which reduce viscosity, 
i.e. promote the disorganized state of such elements. Our data do not indicate 
whether colchicine affects the organized molecules directly or whether it affects 
indirectly the maintenance of the gelated condition. In the former case,  how- 
ever, the direct effect would have to be such that it interferes not with efficient 
solation, but only with subsequent recovery (Text-fig. 13). Our findings support 
the view of Godman (7) that "whatever the mechanism of the action of colchi- 
cine on  anisotropic  systems,  it  appears  to  result  finally in  a  more  random 
arrangement of particles. This evidently may be elicited in celt components of 
fibrillar arrangement concerned with structure and movement, whether in the STEPHEN  E.  ~IALAWISTA  381 
hyaloplasm or ectoplasm, the atractoplasm (achromatic figure) or the muscle 
proto-fibrils." 
With the findings in the melanocyte model added to what has been learned 
in other systems, a general formulation may be drawn for the action of colchi- 
cine: 
1.  Living cells  contain organized,  labile,  fibrillar  systems concerned with 
structure and movement. 
2.  The viscosity, or degree of gelation, in these systems is determined through 
a  dynamic equilibrium between gel and sol, organization and disorganization, 
whose setting at any given time is established by cellular homeostatic mech- 
anisI~. 
3.  Colchicine,  in  low  concentration  and  in  a  dosage-dependent  manner, 
lowers the potential limit of gelation. 
4.  The effect per se is not lethal, and is eventually reversible, provided that 
the cell does not succumb to some other influence during the period of colchi- 
cine action. 
5.  The binding of colchicine to its cellular targets is rapid. 
(a)  If the initial protoplasmic viscosity is low, inhibition of gelation will be 
seen rapidly. 
(b)  If the initial protoplasmic viscosity is high, time will be required for a 
new equilibrium to be established. In the melanocyte model, this time accounts 
for the "late recognition" of the colchicine effect. 
(i) The time required to reach the new equilibrium will be decreased by 
any agent that interferes, directly or indirectly, with maintenance of the 
gelated state. In the melanocyte model, such an agent promotes "early 
recognition" of the colchicine effect; it appears "synergistic" to colchicine. 
(ii) In contrast, the time required to reach the new equilibrium will be in- 
creased by any agent that augments or maintains, directly or indirectly, 
the gelated state. In the melanocyte model, such an agent promotes "very 
late  recognition" of  the  colchicine  effect; it  appears  "antagonistic" to 
colchicine. 
Significance of the Melanocyte Model and of the New Interpretation  of Colchicine 
Action.--Colchicine interferes with the reversible control of granule movement 
by a number of substances of physiologic and pharmacologic interest, and does 
so in an orderly, predictable and reproducible fashion. Furthermore, it operates 
in  a  consistent manner,  regardless of  the  particular darkening or  lightening 
agent used. By this virtue, colchicine becomes a  tool with which to study, in 
live cells, biological effects of controlled physical alteration; until now, this use 
of colchicine has been formally pursued only in the special case of the mitotic 
apparatus.  Though  the  melanocyte  is  convenient  for  such  studies,  similar 
application may be possible in other cell systems. If such models can be uti- 382  ACTION  O:F  COLCHICINE 
lized, then colchicine, beyond its unique and prestigious career in cytogenetic 
studies and in gout, would become a biophysical tool of considerable power. 
SUMMARY 
The effect of colchicine was  studied on the  rapid,  reversible darkening of 
frog  skin  under  the  influence  of  melanocyte-stimulating  hormone  (MSH). 
Darkening  is  due  to  dispersion  of melanin  granules  in  melanocytes  and  is 
thought to be accompanied by a  gel-to-sol cytoplasmic transformation. Mter 
subsequent washing,  the skin lightens,  with aggregation of melanin granules 
and cytoplasmic gelation. 
Preincubation of skin with colchicine had the following effects: 
1.  Darkening induced by MSH was increased in comparison to control skins, 
and on removal of MSH, lightening was inhibited. Inhibition was a function of 
both concentration (1  X  10  -5 to 9 X  10-  ~  ~) and exposure time (2 to 30 min- 
utes). Once established, inhibition was maintained throughout the remainder 
of the experiment. 2.  The same  effects were noted  (a)  when darkening  was 
effected by agents other than MSH (ATP, 0.9 X  10  -3 M; caffeine, 5.2 X  10  -8 M; 
ethyl acetate, 0.8 X  10  -3 ~r), and (b) when lightening was effected by addition 
of chemical agents  (melatonin,  4.3  X  10-  l° ~;  hydrocortisone,  1  X  10  -3 ~r; 
norepinephrine, 1  X  10-  3 M),  instead of by washing.  3. Colchicine alone pro- 
duced a  gradual,  irreversible, dosage-dependent darkening over several hours. 
This darkening was inhibited by melatonin, 4.3  X  10-  l° M. 
The melanocyte model is used  to  construct a  general theory of colchicine 
action on living cells,  an action resulting in decreased protoplasmic viscosity. 
In this formulation colchicine lowers the potential limit of protoplasmic gela- 
tion, and does it rapidly, reversibly, in low concentration, in a dosage-depend- 
ent manner, and without killing the cell.  The theory allows interpretation of 
"synergism" and "antagonism" to colchicine by other substances. It suggests a 
tentative approach to  the understanding  of colchicine action in acute gouty 
arthritis,  where  interference with  ameboid  activities  of  polymorphonuclear 
leukocytes is one possible aspect of the anti-inflammatory effect of colchicine. 
Finally,  the colchicine-treated melanocyte is viewed as a  good, live physical 
model that can be used to elucidate some fundamental biological properties. 
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EXPLANATION OF PLATES 
The colchicine effect is shown in consecutive sets of photomicrographs. The position 
of melanin granules in melanocytes is seen in representative fields. 
PLATE 25 
FIGS. 1 a  to 1 d.  Four samples of skin from a single frog, a few minutes after pre- 
incubation of samples a and c with colchicine,  9  ×  10  -5 •  for 30 minutes (see text). 
Water immersion. Approximately  X  140. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  122  PLATE 25 
(Malawista: Action of colchicine) PLATE  26 
FIC,  S. 2 a to 2 d.  The same four samples of skin as in Figs.  1 a  to 1 d, 1~/~ hours after 
MSH was added  to samples a  and  b  (see  text).  Water  immersion.  Approximately  X 
140. THE  JOURNAL  OP  EXPERIMENTAL  MEDICINE  VOL.  122  PLATE  26 
(Malawista: Action of colchicine) PLATE  27 
FIGS.  3  a  to  3  d.  The  same  four samples  of skin  as  in  Figs.  2  a  to  2  d,  after all 
samples  have  been  washed  twice over a  period  of  2~,~ hours  (see  text).  Water  im- 
mersion. Approximately  X  140. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 122  PLATE  27 
(Malawista: Action of colchicine) 